TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
Boudreau R, Clark M, Nkansah E
Record ID 32010001042
English
Authors' objectives:
To examine the comparative clinical and cost effectiveness of TomoTherapy, GammaKnife, and CyberKnife therapies for patients with cancer of the lung, central nervous system, or intra-abdomen.
Authors' recommendations:
Evidence is insufficient to reliably estimate the comparative clinical effectiveness (benefit and harm), cost effectiveness, and impact on quality of life of TomoTherapy, Gamma Knife surgery (GKS), or CyberKnife surgery (CKS). The specific patient caseloads and sites requiring radiosurgery or radiotherapy may be factors to consider before purchasing.
Details
Project Status:
Completed
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Lung Neoplasms
- Neoplasms
- Peritoneal Neoplasms
- Radiosurgery
- Retroperitoneal Neoplasms
- Tomography, Spiral Computed
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.